Acuta Capital Partners, LLC Avidity Biosciences, Inc. Transaction History

Acuta Capital Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$20.4 - $28.66 $1.22 Million - $1.72 Million	-60,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$19.62 - $29.26 $431,640 - $643,720	-22,000 Reduced 26.83%	60,000 $1.48 Million
Q1 2021 May 17, 2021	SELL	$20.28 - $28.15 $3.33 Million - $4.62 Million	-164,200 Reduced 66.69%	82,000 $1.79 Million
Q4 2020 Feb 16, 2021	BUY	$24.73 - $35.12 $276,976 - $393,344	11,200 Added 4.77%	246,200 $6.28 Million
Q3 2020 Nov 16, 2020	BUY	$23.35 - $35.94 $2.74 Million - $4.22 Million	117,500 Added 100.0%	235,000 $6.62 Million
Q2 2020 Aug 14, 2020	BUY	$26.62 - $31.5 $3.13 Million - $3.7 Million	117,500 New	117,500 $3.32 Million

256

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.28B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.